Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation

Circulation

Volumn 95, Issue 12, 1997, Pages 2660-2667

  Aaronson, Keith D ^a,b   Schwartz, J Sanford ^c   Chen, Tze Ming ^c   Wong, Kar Lai ^c   Goin, James E ^c   Mancini, Donna M ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c NONE

Author keywords

Heart failure; Predictive models; Risk factors; Survival

Indexed keywords

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; HEART CATHETERIZATION; HEART INDEX; HEART PERFORMANCE; HEART TRANSPLANTATION; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030950627     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.12.2660     Document Type: Article

References (53)

1. Konstam M, Dracup K, Brooks N, Dacey R, Dunbar S, Jackson A, Jessup M, Johnson J, Jones R, Luchi R, Massie B, Pitt B, Rose E, Rubin L, Wright R. Heart Failure Evaluation and Care of Patients with Left Ventricular Systolic Dysfunction - Clinical Practice Guideline No. 11. Rockville, Md: Agency for Health Care Policy and Research; June 1994. US Dept of Health and Human Services publication No. 94-0612.
2. a. 1995 Annual Report of the US Scientific Registry for Transplant Recipients and the Organ Procurement and Transportation Network. Data 1988-1994. UNOS, Richmond, Va, and the Division of Transplantation, Bureau of Health Resources Development, Health Resources, and Services Administration. US Department of Health and Human Services, Rockville, Md.
3. Stevenson L, Warner S, Steimle A, Fonarow G, Hamilton M, Moriguchi J, Kobashigawa J, Tillisch J, Drinkwater D. The impending crisis awaiting cardiac transplantation: modeling a solution based on selection. Circulation. 1994;89:450-457.
4. Mancini D, Eisen H, Kussmaul W, Mull R, Edmunds L, Wilson J. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778-786.
5. Wilson J, Schwartz J, Sutton M, Ferraro N, Horowitz L, Reichek N, Josephson M. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol. 1983;2:403-410.
6. Cohn J, Levine T, Olivari M, Garberg V, Lura D, Francis G, Simon A, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984; 311:819-823.
7. Unverferth D, Magorien R, Moeschberger M, Baker P, Fetters J, Leier C. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 1984;54:147-152.
8. Likoff MJ, Chandler S, Kay H. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol. 1987;59:634-638.
9. Cohn J, Rector T. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol. 1988;62:25A-30A.
10. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S, for the Captopril-Digoxin Study Group. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol. 1989;14:564-570.
11. Rockman H, Juneau C, Chatterjee K, Rouleau J-L. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1989;64:1344-1348.
12. Keogh A, Baron D, Hickie J. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol. 1990;65:903-908.
13. Kelly T, Cremo R, Nielson C, Shabetai R. Prediction of outcome in late-stage cardiomyopathy. Am Heart J. 1990; 119:1111-1121.
14. Griffin B, Shah P, Ferguson J, Rubin S. Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am J Cordiol. 1991;67:848-853.
15. Parameshwar J, Keegan J, Sparrow J, Sutton G, Poole-Wilson P. Predictors of prognosis in severe chronic heart failure. Am Heart J. 1992;123:421-426.
16. Cohn J, Johnson G, Shabetai R, Loeb H, Tristani F, Rector T, Smith R, Fletcher R, for the V-HeFT VA Cooperative Studies Group. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation. 1993; 87(suppl VI):VI-5-VI-16.
17. Campana C, Gavazzi A, Berzuini C, Larizza C, Marioni R, D'Armini A, Pederzolli N, Martinelli L, Vigano M. Predictors of prognosis in patients awaiting heart transplantation. J Heart Lung Transplant. 1993;12:756-765.
18. Anguita M, Arizon J, Bueno G, Latre J, Sancho M, Torres F, Gimenez D, Concha M, Valles F. Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 1993;72:413-417.
19. Madsen B, Keller N, Christiansen E, Christensen N. Prognostic value of plasma catecholamines, plasma renin activity, and plasma atrial natriurctic peptide at rest and during exercise in congestive heart failure: comparison with clinical evaluation, ejection fraction, and exercise capacity. J Cardiac Failure. 1995;1:207-216.
20. Stevenson L, Couper G, Natterson B, Fonarow G, Hamilton M, Woo M, Creaser J. Target heart failure populations for new therapies. Circulation. 1995;92(suppl II):II-174-II-181.
21. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
22. 2 for patients with severe heart failure? J Heart Lung Transplant. 1995;14:981-989. Published erratum appears in J Heart Lung Transplant. 1996;15:106-107.
23. 2 for patients with severe heart failure? J Heart Lung Transplant. 1995;14:981-989. Published erratum appears in J Heart Lung Transplant. 1996;15:106-107.
24. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
25. Peto R, Peto L. Asymptotically efficient rank invariant procedures. J R Stat Soc. 1972;135:185-207.
26. Cox D. Regression models and life-tables (with discussion). J R Stat Soc. 1972;34:187-202.
27. Lee E. Statistical Methods for Survival Data Analysis. New York, NY: John Wiley & Sons Inc; 1992:250-263.
28. Harrell FE Jr, Lee KL, Matchar DR, Reichert TA. Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep. 1985;69:1071-1077.
29. Hosmer D, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989:82-83.
30. Charlson M, Ales K, Simon R, MacKenzie R. Why predictive indexes perform less well in validation studies: is it magic or methods? Arch Intern Med. 1987;147:2155-2161.
31. Harrell F, Lee K, Califf R, Pryor D, Rosati R. Regression modelling strategies for improved prognostic prediction. Stat Med. 1984;3: 143-152.
32. Hanley J, McNeil B. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143: 29-36.
33. Harrell F, Califf R, Pryor D, Lee K, Rosati R. Evaluating the yield of diagnostic tests. JAMA. 1982;247:2543-2546.
34. Hanley J, McNeil B. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843.
35. Pierce J, Cornell R. Integrating stratum-specific likelihood ratios with the analysis of ROC curves. Med Decis Making. 1993;13: 141-151.
36. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983; 51:831-836.
37. Szlachcic J, Massie B, Kramer B, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985;55:1037-1042.
38. Cohn J, Archibald D, Ziesche S, Franciosa J, Harston W, Tristani F, Dunkman S, Jacobs W, Francis G, Flohr K, Goldman S, Cobb F, Shah P, Saunders R, Fletcher R, Leob H, Hughes V, Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314:1547-1552.
39. Lee W, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation. 1986;73: 257-267.
40. Mancini D, Wong K, Simson M. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation. 1993;87:1083-1092.
41. Costard-Jackle A, Fowler M. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992; 19: 48-54.
42. Wasson J, Sox J, Neff R, Goldman L. Clinical prediction rules: applications and methodological standards. N Engl J Med. 1985;313: 793-799.
43. Waagstein F, Bristow M, Swedberg K, Camerini F, Fowler M, Silver M, Gilbert E, Johnson M, Goss F, Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993; 342:1441-1446.
44. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 1994;90:1765-1773.
45. Sackner-Bernstein J, Mancini D. Rationale for treatment of patients with chronic heart failure with adrenergic blockade. JAMA. 1995;274:1462-1467.
46. Packer M, Bristow M, Cohn J, Colucci W, Fowler M, Gilbert E, Shusterman N. Effect of carvedilol on morbidity and mortality in chronic heart failure: US Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-1355.
47. Follansbee WP, Michelson EL, Morganroth J. Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death. Ann Intern Med. 1980;92: 741-747.
48. Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, Pop T, Leitner E, Andresen D, Meyer J. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol. 1984;53:902-907.
49. Gottlieb S, Kukin M, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989;13:1534-1539.
50. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
51. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS Trial Study Group. Hormones regulating cardiovascular function in patients with chronic congestive heart failure and their relation to mortality. Circulation. 1990;82:1730-1736.
52. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli P. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995;92:1479-1486.
53. Stevenson L. Tailored therapy before transplantation for effective treatment of advanced heart failure: effective use of vasodilators and diuretics. J Heart Lung Transplant. 1991;10:468-476.